Skip to main content

Table 3 Comparisons between patients with IMV and non-IMV (Median, IQR)

From: Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers

 Non-intubated group
n = 5
IMV group
n = 5
P value
Male(n,%)4 (80%)2 (40%)0.003*
Age (year)42 (30–49)17 (16–33)0.032*
APACHEII6 (4–12)17 (11–21)0.028*
PaO2/FiO2230 (159–262)96 (51–158)0.032*
Lactate0.9 (0.7–1.3)1.3 (1.2–1.7)0.056
Breathing rate (breaths/min)26 (25–31)27 (23–29)0.690
Tmax((°C))40 (39.5–41.3)40 (39.7–40.9)0.841
Procalcitonin0.175 (0.14–0.195)1.05 (0.45–2.09)0.016*
White blood cell count(109/L)4.5 (3.8–7.3)7.6 (5.5–8.7)0.151
Neutrophil proportion(%)73 (54–82)92 (83–94)0.016*
AST (U/L)81 (33–102)100 (41–121)0.548
Albumin (g/L)29 (28–34)32 (26–39)1.0
Pre-albumin (g/L)0.08 (0.02–0.15)0.03 (0.03–0.04)0.571
Creatine (umol/L)55 (47–69)43 (35–76)1.0
C-reactive protein (CRP, mg/L)17 (6–48)93 (11–209)0.286
Erythrocyte sedimentation rate (ESR,mm/h)25 (5.5–28.5)12 (4–25)0.675
Length of onset to ICU admission (days)11 (9.5–14)14 (7.5–15)0.421
Length of ICU stay (days)4 (3–18.5)13 (17.5–23.5)0.056
  1. APACHE II Acute physiological and chronic health evaluation II score; *P < 0.05